Usana Health Sciences Inc (STU:USJ)
€ 18.9 -0.30 (-1.56%) Market Cap: 363.16 Mil Enterprise Value: 277.44 Mil PE Ratio: 46.92 PB Ratio: 0.75 GF Score: 67/100

Q4 2024 USANA Health Sciences Inc Earnings Call Transcript

Feb 26, 2025 / 04:00PM GMT
Release Date Price: €31 (+5.44%)

Key Points

Positve
  • Usana Health Sciences Inc (USNA) reported a solid fourth quarter with net sales growing 7% sequentially and adjusted diluted EPS increasing by 14%.
  • The acquisition of a 78.8% ownership stake in Hiya Health positions Usana as a leader in the expanding children's health and wellness market.
  • Usana's reorganization of its R&D and commercial teams has led to faster and more efficient product development and market differentiation.
  • The company plans to launch over 20 new products and product reformulations globally in 2025, enhancing its product offerings.
  • Usana's strategic enhancements to its associate incentive offerings are expected to modernize sales incentives and improve pay for performance.
Negative
  • The contribution of Hiya Health to Usana's consolidated 2024 results was minimal due to the late acquisition in the fourth quarter.
  • Usana faces challenges in certain regions, such as China, where the operating environment remains tough.
  • SG&A expenses as a percentage of sales came in higher than expected, partly due to the commercial team reorganization.
  • The integration of Hiya Health may incur short-term costs and potential disruptions in profitability due to customer acquisition expenses.
  • Usana's balance sheet has been impacted by the Hiya acquisition, resulting in no stock buybacks and a slight increase in debt.
Operator

Greetings and welcome to the USANA Health Sciences fourth quarter conference call.

At this time, all participants are in a listen-only mode. A question and answer session will follow a formal presentation.

(Operator Instructions)

Please note this conference is being recorded. I will now turn the conference over to your host, Andrew Masuda, Director of Investor Relations.

Thank you. You may begin.

Andrew Masuda Usana Health Sciences Inc.;Director of Investor Relations

Thanks, Diego, and good morning everyone. We appreciate you joining us to review our fourth quarter and fiscal year 2024 results. Today's conference call is being broadcast live via webcast and can be accessed directly from our website at ir.usana.com. Shortly following the call, a replay will be available on our website.

As a reminder, during the course of this conference call, management will make forward-looking statements regarding future events or the future financial performance of our company. Those statements involve risks and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot